Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cellectis S.A. CMVLF OTC

Other OTC • Healthcare • Biotechnology • FR • USD

SharesGrow Score
35/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cellectis S.A. (CMVLF) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 7 Buy, 2 Hold, 1 Sell.

CMVLF Analyst Ratings

Buy
10
Ratings
7 Buy
2 Hold
1 Sell
Based on 10 analysts giving stock ratings to Cellectis S.A. in the past 3 months
Rating breakdown
Buy
7 70%
Hold
2 20%
Sell
1 10%
70%
Buy
7 analysts
20%
Hold
2 analysts
10%
Sell
1 analysts

People Also View

CVALF
CVALF
Covalon Technologies Ltd.
$1.45
+0.69%
 DMTTF
DMTTF
Small Pharma Inc.
$0.11
-9.69%
 BITRF
BITRF
Biotron Limited
$0.03
+0.00%
 RVXCF
RVXCF
Resverlogix Corp.
$0.08
+4.55%
 CRPOF
CRPOF
Ceapro Inc.
$0.17
-13.04%
 CPMV
CPMV
Mosaic ImmunoEngineering Inc.
$0.70
-6.71%
 CHNXF
CHNXF
ChitogenX Inc.
$0.01
+0.00%
 APTCF
APTCF
Advanced Proteome Therapeutics Corporation
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message